Alzheimer’s disease (AD) is caused by synaptic failure and the excessive accumulation of misfolded proteins especially Aβ and tau, and associated with memory loss and cognitive impairment. Treatment of AD mainly con...Alzheimer’s disease (AD) is caused by synaptic failure and the excessive accumulation of misfolded proteins especially Aβ and tau, and associated with memory loss and cognitive impairment. Treatment of AD mainly consists of symptomatic therapy and disease-modifying therapy (DMT). Several monotherapies including small molecules or antibodies have been evaluated through multiple clinical trials, but a very few have been approved by the USFDA to intervene the disease’s pathogenesis. Past research has shown multifactorial nature of AD, therefore, multi-target drugs were proposed to target different pathways at the same time, however, currently no rationally designed multi-target directed ligand (MTDL) has been clinically approved. Different combinations and bispecific antibodies are also under development. Novel approaches like stem cell-based therapies, microRNAs, peptides, ADCs and vaccines cast a new hope for AD treatment, however, a number of questions remained to be answered prior to their safe and effective clinical translation. This review explores the small molecules, MTDL, and antibodies (monospecific and bispecific) for the treatment of AD. Finally, future perspectives (stem cell therapy, PROTAC approaches, microRNAs, ADC, peptides and vaccines) are also discussed with regard to their clinical applications and feasibility.展开更多
Encoding information using the topological charge of vortex beams has been proposed for optical communications. The conservation of the topological charge on propagation and the detection of the topological charge by ...Encoding information using the topological charge of vortex beams has been proposed for optical communications. The conservation of the topological charge on propagation and the detection of the topological charge by a receiver are significant in these applications and have been well established in free-space. However, when vortex beams enter a diffuser,the wavefront is distorted, leading to a challenge in the conservation and detection of the topological charge. Here, we present a technique to measure the value of the topological charge of a vortex beam obscured in the randomly scattered light. The results of the numerical simulations and experiments are presented and are in good agreement. In particular, only a single-shot measurement is required to detect the topological charge of vortex beams, indicating that the method is applicable to a dynamic diffuser.展开更多
Recently a lot of medical tablets with special packets in the global market are available. For the safety and purity of the tablet, we need to scan it by developed scanner technology, which should be not more expensiv...Recently a lot of medical tablets with special packets in the global market are available. For the safety and purity of the tablet, we need to scan it by developed scanner technology, which should be not more expensive and easily available in the market. The THz technology is one of them. In the proposed work, we have tasted tablet images with the help of the THz super-resolution scanner, which is already available in our lab. The AI machine learning data concept has been investigated. Good resolution of images has been obtained. Furthermore, the challenging research problems are discussed. Finally, it summarizes the recent updates in terahertz technology for drug inspection and medical applications with potential research challenges.展开更多
文摘Alzheimer’s disease (AD) is caused by synaptic failure and the excessive accumulation of misfolded proteins especially Aβ and tau, and associated with memory loss and cognitive impairment. Treatment of AD mainly consists of symptomatic therapy and disease-modifying therapy (DMT). Several monotherapies including small molecules or antibodies have been evaluated through multiple clinical trials, but a very few have been approved by the USFDA to intervene the disease’s pathogenesis. Past research has shown multifactorial nature of AD, therefore, multi-target drugs were proposed to target different pathways at the same time, however, currently no rationally designed multi-target directed ligand (MTDL) has been clinically approved. Different combinations and bispecific antibodies are also under development. Novel approaches like stem cell-based therapies, microRNAs, peptides, ADCs and vaccines cast a new hope for AD treatment, however, a number of questions remained to be answered prior to their safe and effective clinical translation. This review explores the small molecules, MTDL, and antibodies (monospecific and bispecific) for the treatment of AD. Finally, future perspectives (stem cell therapy, PROTAC approaches, microRNAs, ADC, peptides and vaccines) are also discussed with regard to their clinical applications and feasibility.
基金supported by the National Natural Science Foundation of China(NSFC)(No.11674111)Fujian Province Science Funds for Distinguished Young Scholar(No.2018J06017)+1 种基金Fundamental Research Funds for the Central Universities(No.ZQN-PY209)Science and Engineering Research Board(SERB)(No.India-EMR/2015/001613)。
文摘Encoding information using the topological charge of vortex beams has been proposed for optical communications. The conservation of the topological charge on propagation and the detection of the topological charge by a receiver are significant in these applications and have been well established in free-space. However, when vortex beams enter a diffuser,the wavefront is distorted, leading to a challenge in the conservation and detection of the topological charge. Here, we present a technique to measure the value of the topological charge of a vortex beam obscured in the randomly scattered light. The results of the numerical simulations and experiments are presented and are in good agreement. In particular, only a single-shot measurement is required to detect the topological charge of vortex beams, indicating that the method is applicable to a dynamic diffuser.
文摘Recently a lot of medical tablets with special packets in the global market are available. For the safety and purity of the tablet, we need to scan it by developed scanner technology, which should be not more expensive and easily available in the market. The THz technology is one of them. In the proposed work, we have tasted tablet images with the help of the THz super-resolution scanner, which is already available in our lab. The AI machine learning data concept has been investigated. Good resolution of images has been obtained. Furthermore, the challenging research problems are discussed. Finally, it summarizes the recent updates in terahertz technology for drug inspection and medical applications with potential research challenges.
